Global CRISPR-Based Therapeutics Market Size, Status and Forecast 2020-2026

Global CRISPR-Based Therapeutics Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by CRISPR-Based Therapeutics Revenue
1.4 Market Analysis by Type
1.4.1 Global CRISPR-Based Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Genome Editing
1.4.3 Genetic Engineering
1.4.4 gRNA Database/Gene Librar
1.4.5 CRISPR Plasmid
1.4.6 Human Stem Cells
1.4.7 Genetically Modified Organisms/Crops
1.4.8 Cell Line Engineering
1.5 Market by Application
1.5.1 Global CRISPR-Based Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Biotechnology Companies
1.5.3 Pharmaceutical Companies
1.5.4 Academic Institutes
1.5.5 Research and Development Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 CRISPR-Based Therapeutics Market Perspective (2015-2026)
2.2 CRISPR-Based Therapeutics Growth Trends by Regions
2.2.1 CRISPR-Based Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 CRISPR-Based Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 CRISPR-Based Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 CRISPR-Based Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key CRISPR-Based Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top CRISPR-Based Therapeutics Players by Market Size
3.1.1 Global Top CRISPR-Based Therapeutics Players by Revenue (2015-2020)
3.1.2 Global CRISPR-Based Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global CRISPR-Based Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global CRISPR-Based Therapeutics Market Concentration Ratio
3.2.1 Global CRISPR-Based Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by CRISPR-Based Therapeutics Revenue in 2019
3.3 CRISPR-Based Therapeutics Key Players Head office and Area Served
3.4 Key Players CRISPR-Based Therapeutics Product Solution and Service
3.5 Date of Enter into CRISPR-Based Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global CRISPR-Based Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global CRISPR-Based Therapeutics Forecasted Market Size by Type (2021-2026)
5 CRISPR-Based Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global CRISPR-Based Therapeutics Market Size by Application (2015-2020)
5.2 Global CRISPR-Based Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America CRISPR-Based Therapeutics Market Size (2015-2020)
6.2 CRISPR-Based Therapeutics Key Players in North America (2019-2020)
6.3 North America CRISPR-Based Therapeutics Market Size by Type (2015-2020)
6.4 North America CRISPR-Based Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe CRISPR-Based Therapeutics Market Size (2015-2020)
7.2 CRISPR-Based Therapeutics Key Players in Europe (2019-2020)
7.3 Europe CRISPR-Based Therapeutics Market Size by Type (2015-2020)
7.4 Europe CRISPR-Based Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China CRISPR-Based Therapeutics Market Size (2015-2020)
8.2 CRISPR-Based Therapeutics Key Players in China (2019-2020)
8.3 China CRISPR-Based Therapeutics Market Size by Type (2015-2020)
8.4 China CRISPR-Based Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan CRISPR-Based Therapeutics Market Size (2015-2020)
9.2 CRISPR-Based Therapeutics Key Players in Japan (2019-2020)
9.3 Japan CRISPR-Based Therapeutics Market Size by Type (2015-2020)
9.4 Japan CRISPR-Based Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia CRISPR-Based Therapeutics Market Size (2015-2020)
10.2 CRISPR-Based Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia CRISPR-Based Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia CRISPR-Based Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India CRISPR-Based Therapeutics Market Size (2015-2020)
11.2 CRISPR-Based Therapeutics Key Players in India (2019-2020)
11.3 India CRISPR-Based Therapeutics Market Size by Type (2015-2020)
11.4 India CRISPR-Based Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America CRISPR-Based Therapeutics Market Size (2015-2020)
12.2 CRISPR-Based Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America CRISPR-Based Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America CRISPR-Based Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Caribou Biosciences
13.1.1 Caribou Biosciences Company Details
13.1.2 Caribou Biosciences Business Overview and Its Total Revenue
13.1.3 Caribou Biosciences CRISPR-Based Therapeutics Introduction
13.1.4 Caribou Biosciences Revenue in CRISPR-Based Therapeutics Business (2015-2020))
13.1.5 Caribou Biosciences Recent Development
13.2 Addgene
13.2.1 Addgene Company Details
13.2.2 Addgene Business Overview and Its Total Revenue
13.2.3 Addgene CRISPR-Based Therapeutics Introduction
13.2.4 Addgene Revenue in CRISPR-Based Therapeutics Business (2015-2020)
13.2.5 Addgene Recent Development
13.3 CRISPR THERAPEUTICS
13.3.1 CRISPR THERAPEUTICS Company Details
13.3.2 CRISPR THERAPEUTICS Business Overview and Its Total Revenue
13.3.3 CRISPR THERAPEUTICS CRISPR-Based Therapeutics Introduction
13.3.4 CRISPR THERAPEUTICS Revenue in CRISPR-Based Therapeutics Business (2015-2020)
13.3.5 CRISPR THERAPEUTICS Recent Development
13.4 Merck KGaA
13.4.1 Merck KGaA Company Details
13.4.2 Merck KGaA Business Overview and Its Total Revenue
13.4.3 Merck KGaA CRISPR-Based Therapeutics Introduction
13.4.4 Merck KGaA Revenue in CRISPR-Based Therapeutics Business (2015-2020)
13.4.5 Merck KGaA Recent Development
13.5 Mirus Bio LLC
13.5.1 Mirus Bio LLC Company Details
13.5.2 Mirus Bio LLC Business Overview and Its Total Revenue
13.5.3 Mirus Bio LLC CRISPR-Based Therapeutics Introduction
13.5.4 Mirus Bio LLC Revenue in CRISPR-Based Therapeutics Business (2015-2020)
13.5.5 Mirus Bio LLC Recent Development
13.6 Editas Medicine
13.6.1 Editas Medicine Company Details
13.6.2 Editas Medicine Business Overview and Its Total Revenue
13.6.3 Editas Medicine CRISPR-Based Therapeutics Introduction
13.6.4 Editas Medicine Revenue in CRISPR-Based Therapeutics Business (2015-2020)
13.6.5 Editas Medicine Recent Development
13.7 Takara Bio USA
13.7.1 Takara Bio USA Company Details
13.7.2 Takara Bio USA Business Overview and Its Total Revenue
13.7.3 Takara Bio USA CRISPR-Based Therapeutics Introduction
13.7.4 Takara Bio USA Revenue in CRISPR-Based Therapeutics Business (2015-2020)
13.7.5 Takara Bio USA Recent Development
13.8 Thermo Fisher Scientific
13.8.1 Thermo Fisher Scientific Company Details
13.8.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
13.8.3 Thermo Fisher Scientific CRISPR-Based Therapeutics Introduction
13.8.4 Thermo Fisher Scientific Revenue in CRISPR-Based Therapeutics Business (2015-2020)
13.8.5 Thermo Fisher Scientific Recent Development
13.9 Horizon Discovery Group
13.9.1 Horizon Discovery Group Company Details
13.9.2 Horizon Discovery Group Business Overview and Its Total Revenue
13.9.3 Horizon Discovery Group CRISPR-Based Therapeutics Introduction
13.9.4 Horizon Discovery Group Revenue in CRISPR-Based Therapeutics Business (2015-2020)
13.9.5 Horizon Discovery Group Recent Development
13.10 Intellia Therapeutics
13.10.1 Intellia Therapeutics Company Details
13.10.2 Intellia Therapeutics Business Overview and Its Total Revenue
13.10.3 Intellia Therapeutics CRISPR-Based Therapeutics Introduction
13.10.4 Intellia Therapeutics Revenue in CRISPR-Based Therapeutics Business (2015-2020)
13.10.5 Intellia Therapeutics Recent Development
13.11 GE Healthcare Dharmacon
10.11.1 GE Healthcare Dharmacon Company Details
10.11.2 GE Healthcare Dharmacon Business Overview and Its Total Revenue
10.11.3 GE Healthcare Dharmacon CRISPR-Based Therapeutics Introduction
10.11.4 GE Healthcare Dharmacon Revenue in CRISPR-Based Therapeutics Business (2015-2020)
10.11.5 GE Healthcare Dharmacon Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. CRISPR-Based Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by CRISPR-Based Therapeutics Revenue
Table 3. Ranking of Global Top CRISPR-Based Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global CRISPR-Based Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Genome Editing
Table 6. Key Players of Genetic Engineering
Table 7. Key Players of gRNA Database/Gene Librar
Table 8. Key Players of CRISPR Plasmid
Table 9. Key Players of Human Stem Cells
Table 10. Key Players of Genetically Modified Organisms/Crops
Table 11. Key Players of Cell Line Engineering
Table 12. Global CRISPR-Based Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global CRISPR-Based Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global CRISPR-Based Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global CRISPR-Based Therapeutics Market Share by Regions (2015-2020)
Table 16. Global CRISPR-Based Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global CRISPR-Based Therapeutics Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. CRISPR-Based Therapeutics Market Growth Strategy
Table 22. Main Points Interviewed from Key CRISPR-Based Therapeutics Players
Table 23. Global CRISPR-Based Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 24. Global CRISPR-Based Therapeutics Market Share by Players (2015-2020)
Table 25. Global Top CRISPR-Based Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR-Based Therapeutics as of 2019)
Table 26. Global CRISPR-Based Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players CRISPR-Based Therapeutics Product Solution and Service
Table 29. Date of Enter into CRISPR-Based Therapeutics Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global CRISPR-Based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 32. Global CRISPR-Based Therapeutics Market Size Share by Type (2015-2020)
Table 33. Global CRISPR-Based Therapeutics Revenue Market Share by Type (2021-2026)
Table 34. Global CRISPR-Based Therapeutics Market Size Share by Application (2015-2020)
Table 35. Global CRISPR-Based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 36. Global CRISPR-Based Therapeutics Market Size Share by Application (2021-2026)
Table 37. North America Key Players CRISPR-Based Therapeutics Revenue (2019-2020) (Million US$)
Table 38. North America Key Players CRISPR-Based Therapeutics Market Share (2019-2020)
Table 39. North America CRISPR-Based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 40. North America CRISPR-Based Therapeutics Market Share by Type (2015-2020)
Table 41. North America CRISPR-Based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 42. North America CRISPR-Based Therapeutics Market Share by Application (2015-2020)
Table 43. Europe Key Players CRISPR-Based Therapeutics Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players CRISPR-Based Therapeutics Market Share (2019-2020)
Table 45. Europe CRISPR-Based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 46. Europe CRISPR-Based Therapeutics Market Share by Type (2015-2020)
Table 47. Europe CRISPR-Based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 48. Europe CRISPR-Based Therapeutics Market Share by Application (2015-2020)
Table 49. China Key Players CRISPR-Based Therapeutics Revenue (2019-2020) (Million US$)
Table 50. China Key Players CRISPR-Based Therapeutics Market Share (2019-2020)
Table 51. China CRISPR-Based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 52. China CRISPR-Based Therapeutics Market Share by Type (2015-2020)
Table 53. China CRISPR-Based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 54. China CRISPR-Based Therapeutics Market Share by Application (2015-2020)
Table 55. Japan Key Players CRISPR-Based Therapeutics Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players CRISPR-Based Therapeutics Market Share (2019-2020)
Table 57. Japan CRISPR-Based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 58. Japan CRISPR-Based Therapeutics Market Share by Type (2015-2020)
Table 59. Japan CRISPR-Based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 60. Japan CRISPR-Based Therapeutics Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players CRISPR-Based Therapeutics Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players CRISPR-Based Therapeutics Market Share (2019-2020)
Table 63. Southeast Asia CRISPR-Based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia CRISPR-Based Therapeutics Market Share by Type (2015-2020)
Table 65. Southeast Asia CRISPR-Based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia CRISPR-Based Therapeutics Market Share by Application (2015-2020)
Table 67. India Key Players CRISPR-Based Therapeutics Revenue (2019-2020) (Million US$)
Table 68. India Key Players CRISPR-Based Therapeutics Market Share (2019-2020)
Table 69. India CRISPR-Based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 70. India CRISPR-Based Therapeutics Market Share by Type (2015-2020)
Table 71. India CRISPR-Based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 72. India CRISPR-Based Therapeutics Market Share by Application (2015-2020)
Table 73. Central & South America Key Players CRISPR-Based Therapeutics Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players CRISPR-Based Therapeutics Market Share (2019-2020)
Table 75. Central & South America CRISPR-Based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America CRISPR-Based Therapeutics Market Share by Type (2015-2020)
Table 77. Central & South America CRISPR-Based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America CRISPR-Based Therapeutics Market Share by Application (2015-2020)
Table 79. Caribou Biosciences Company Details
Table 80. Caribou Biosciences Business Overview
Table 81. Caribou Biosciences Product
Table 82. Caribou Biosciences Revenue in CRISPR-Based Therapeutics Business (2015-2020) (Million US$)
Table 83. Caribou Biosciences Recent Development
Table 84. Addgene Company Details
Table 85. Addgene Business Overview
Table 86. Addgene Product
Table 87. Addgene Revenue in CRISPR-Based Therapeutics Business (2015-2020) (Million US$)
Table 88. Addgene Recent Development
Table 89. CRISPR THERAPEUTICS Company Details
Table 90. CRISPR THERAPEUTICS Business Overview
Table 91. CRISPR THERAPEUTICS Product
Table 92. CRISPR THERAPEUTICS Revenue in CRISPR-Based Therapeutics Business (2015-2020) (Million US$)
Table 93. CRISPR THERAPEUTICS Recent Development
Table 94. Merck KGaA Company Details
Table 95. Merck KGaA Business Overview
Table 96. Merck KGaA Product
Table 97. Merck KGaA Revenue in CRISPR-Based Therapeutics Business (2015-2020) (Million US$)
Table 98. Merck KGaA Recent Development
Table 99. Mirus Bio LLC Company Details
Table 100. Mirus Bio LLC Business Overview
Table 101. Mirus Bio LLC Product
Table 102. Mirus Bio LLC Revenue in CRISPR-Based Therapeutics Business (2015-2020) (Million US$)
Table 103. Mirus Bio LLC Recent Development
Table 104. Editas Medicine Company Details
Table 105. Editas Medicine Business Overview
Table 106. Editas Medicine Product
Table 107. Editas Medicine Revenue in CRISPR-Based Therapeutics Business (2015-2020) (Million US$)
Table 108. Editas Medicine Recent Development
Table 109. Takara Bio USA Company Details
Table 110. Takara Bio USA Business Overview
Table 111. Takara Bio USA Product
Table 112. Takara Bio USA Revenue in CRISPR-Based Therapeutics Business (2015-2020) (Million US$)
Table 113. Takara Bio USA Recent Development
Table 114. Thermo Fisher Scientific Business Overview
Table 115. Thermo Fisher Scientific Product
Table 116. Thermo Fisher Scientific Company Details
Table 117. Thermo Fisher Scientific Revenue in CRISPR-Based Therapeutics Business (2015-2020) (Million US$)
Table 118. Thermo Fisher Scientific Recent Development
Table 119. Horizon Discovery Group Company Details
Table 120. Horizon Discovery Group Business Overview
Table 121. Horizon Discovery Group Product
Table 122. Horizon Discovery Group Revenue in CRISPR-Based Therapeutics Business (2015-2020) (Million US$)
Table 123. Horizon Discovery Group Recent Development
Table 124. Intellia Therapeutics Company Details
Table 125. Intellia Therapeutics Business Overview
Table 126. Intellia Therapeutics Product
Table 127. Intellia Therapeutics Revenue in CRISPR-Based Therapeutics Business (2015-2020) (Million US$)
Table 128. Intellia Therapeutics Recent Development
Table 129. GE Healthcare Dharmacon Company Details
Table 130. GE Healthcare Dharmacon Business Overview
Table 131. GE Healthcare Dharmacon Product
Table 132. GE Healthcare Dharmacon Revenue in CRISPR-Based Therapeutics Business (2015-2020) (Million US$)
Table 133. GE Healthcare Dharmacon Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRISPR-Based Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Genome Editing Features
Figure 3. Genetic Engineering Features
Figure 4. gRNA Database/Gene Librar Features
Figure 5. CRISPR Plasmid Features
Figure 6. Human Stem Cells Features
Figure 7. Genetically Modified Organisms/Crops Features
Figure 8. Cell Line Engineering Features
Figure 9. Global CRISPR-Based Therapeutics Market Share by Application: 2020 VS 2026
Figure 10. Biotechnology Companies Case Studies
Figure 11. Pharmaceutical Companies Case Studies
Figure 12. Academic Institutes Case Studies
Figure 13. Research and Development Institutes Case Studies
Figure 14. CRISPR-Based Therapeutics Report Years Considered
Figure 15. Global CRISPR-Based Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global CRISPR-Based Therapeutics Market Share by Regions: 2020 VS 2026
Figure 17. Global CRISPR-Based Therapeutics Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global CRISPR-Based Therapeutics Market Share by Players in 2019
Figure 20. Global Top CRISPR-Based Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR-Based Therapeutics as of 2019
Figure 21. The Top 10 and 5 Players Market Share by CRISPR-Based Therapeutics Revenue in 2019
Figure 22. North America CRISPR-Based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe CRISPR-Based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China CRISPR-Based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan CRISPR-Based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia CRISPR-Based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India CRISPR-Based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America CRISPR-Based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Caribou Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Caribou Biosciences Revenue Growth Rate in CRISPR-Based Therapeutics Business (2015-2020)
Figure 31. Addgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Addgene Revenue Growth Rate in CRISPR-Based Therapeutics Business (2015-2020)
Figure 33. CRISPR THERAPEUTICS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. CRISPR THERAPEUTICS Revenue Growth Rate in CRISPR-Based Therapeutics Business (2015-2020)
Figure 35. Merck KGaA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Merck KGaA Revenue Growth Rate in CRISPR-Based Therapeutics Business (2015-2020)
Figure 37. Mirus Bio LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Mirus Bio LLC Revenue Growth Rate in CRISPR-Based Therapeutics Business (2015-2020)
Figure 39. Editas Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Editas Medicine Revenue Growth Rate in CRISPR-Based Therapeutics Business (2015-2020)
Figure 41. Takara Bio USA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Takara Bio USA Revenue Growth Rate in CRISPR-Based Therapeutics Business (2015-2020)
Figure 43. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Thermo Fisher Scientific Revenue Growth Rate in CRISPR-Based Therapeutics Business (2015-2020)
Figure 45. Horizon Discovery Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Horizon Discovery Group Revenue Growth Rate in CRISPR-Based Therapeutics Business (2015-2020)
Figure 47. Intellia Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Intellia Therapeutics Revenue Growth Rate in CRISPR-Based Therapeutics Business (2015-2020)
Figure 49. GE Healthcare Dharmacon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. GE Healthcare Dharmacon Revenue Growth Rate in CRISPR-Based Therapeutics Business (2015-2020)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs